Microbiome diversity in your report: what the score really tells you
ca. 19 Minuten

The key points at a glance
The diversity score describes two things at once: how many different groups of bacteria the lab found in your sample and how evenly those groups are distributed in it. The number is a snapshot of your own gut flora. It is not a grade or a statement about your health.
This article takes the score apart: how it is calculated, why it can hardly be compared with other people’s scores, what moves it up and down, and where its explanatory power ends.
If you have the report in front of you, start with Chapter 1. Chapter 2 explains the calculation behind it, Chapter 3 the comparison problem, and Chapter 5 gathers everything the number cannot tell you.
What to expect in this article
1. Where the number appears in the report and what appears beside it
2. What the diversity score actually measures
3. Why your number is not the same as someone else’s
4. What moves the score up or down
5. What cannot be inferred from the score
6. Which test reports a diversity score
7. Is a second measurement worthwhile?
8. What you can do with the number
Frequently asked questions
Sources
Where the number appears in the report and what appears beside it
A microbiome report consists of two very different parts. One is a long list of bacterial names with quantity figures, often spanning several pages. The other consists of a few summary metrics calculated from that exact list. The diversity score belongs to the second part.
That explains why the number gets so much attention. It is usually near the top, often with a bar or color beside it, and it looks like a result. The species list below looks like extra detail. In fact, it’s the other way around: the list is the measurement, and the diversity score is a summary of it.
A summary always loses information. Two people can have the same diversity score and carry completely different bacteria in their guts. The score says something about the structure of the ecosystem, not who lives in it.
Key point
The diversity score is not a measurement result, but a calculation based on the measurement result. It describes the structure of your gut flora, not its composition in detail.
Four questions this article does not answer
Several questions arise at once around a microbiome report, and they need different answers. Four of them are deliberately set aside here because they are answered in detail elsewhere.
The article Getting Your Gut Flora Tested explains which test is right for your question and how to recognize a reputable provider. Your At-Home Gut Test explains how to collect a sample at home. Building Up Your Gut Flora answers how long it takes for the gut flora to change at all. And Making Sense of Abdominal Symptoms explains where different abdominal symptoms fit.
Here, we’re focusing solely on the one number already shown on your report. Not on the choice or setup, but on interpreting a value you already have.
What the diversity score actually measures
The score consists of two components that are usually combined into a single number in the report. The first is species richness: how many distinct bacterial groups were detected at all. The second is evenness: how the total found is distributed across these groups.
Imagine two gardens, each with twenty plant species. In the first, roughly the same number of plants of each species grows. In the second, a single grass species overgrows almost the entire area, while the other species stand as isolated plants at the edge. Both gardens have the same species richness. Only the first has high diversity.
That is exactly why the number of species alone is not enough as a metric. A report that only counts how many species were found overlooks the imbalance in the second garden. A diversity score that combines both components captures it.
In the mybody®x Gut Encyclopedia (MYBODY Lab GmbH), bacterial diversity is listed under Metrics and Indices. The explanation there summarizes both components in one sentence: “Diversity shows how many different bacterial species live in your gut and how evenly they are distributed.” (Gut Encyclopedia, accessed on 27.08.2026)
Diversity within a sample and diversity between two samples
In microbiological terminology, the value shown in your report has a more precise name. Alpha diversity describes diversity within a single sample, that is, exactly what species richness and evenness together represent. It is the measure that appears as your number.
Alongside this is beta diversity. It describes not the diversity within a sample, but the distance between two samples: how differently two gut floras are composed. You need this second measure if you want to relate today's measurement to your measurement from a year ago.
The difference has a practical consequence. Two people can have nearly the same alpha diversity and still have a large difference in beta diversity - their gut flora can be similarly broad in composition, yet consist of different inhabitants. If you read only one number, you won't see this difference.
How diversity differs from neighboring values
Alongside diversity, the report includes other metrics calculated from the same species list that nevertheless describe something different. Confusing them can lead you to read reassurance into an unremarkable diversity value that it does not provide. The table compares three of these metrics using the same criteria.
| Criterion | Bacterial diversity | Firmicutes-Bacteroidetes ratio | Butyrate production potential |
|---|---|---|---|
| What the metric describes | number of species found and their distribution relative to each other | the baseline distribution of two major bacterial phyla relative to each other | the calculated potential of the flora found to produce butyric acid |
| What it is based on | from the complete species list, combining number and distribution | from the ratio of the quantities of two groups, regardless of the number of species | from the proportion of species attributed with this ability |
| What a high value suggests | a broadly composed ecosystem in this one sample | a shift in favor of one of the two phyla | a higher calculated production potential, not a measured amount |
| Target value for individuals | No documented target value in the source material used | No documented target value in the source material used | No documented target value in the source material used |
| What it does not show | says nothing about which species were found | says nothing about the diversity within the two phyla | does not replace a measurement of the amount actually produced |
The last row is the most important. Each of these metrics answers exactly one question and says nothing about all the others. So if you want to read the report as a whole, read them side by side, not one after another.
The fourth row is the most uncomfortable. The source material used provides no target value for any of the three metrics that applies to an individual. This is not a gap in this article, but the state of the evidence.
Why your number is not someone else’s number
The first instinct after receiving a result is to compare. Someone posts their number in a forum, someone else mentions theirs in conversation, and suddenly your own number is sitting beside them, seeming too low or too high. This comparison is less informative than it promises to be.
On February 3, 2026, the German Federal Institute for Risk Assessment issued a statement on bacterial additives in infant formula. The statement addresses a different topic than your test result, but it contains a sentence about the baseline situation that applies to every microbiome measurement.
Cited source
“Human studies suggest that there are large interindividual differences in the composition of the human gut microbiota.”
German Federal Institute for Risk Assessment (BfR)
Statement 005/2026 on “Probiotics” in Infant Formula, February 3, 2026
Interindividual means from person to person. So the differences between two healthy people are large from the outset. A number below average for you may be well above average for someone else with the same lifestyle, without either of you having a problem.
In the same statement, the BfR also explains what these differences depend on. For early colonization, it cites factors including gestational age, mode of delivery, feeding method, antibiotic use, and family, geographic, and cultural influences (BfR, 2026). Some of these factors date back decades and can no longer be changed.
Key point
The most meaningful comparison for your diversity value is your own value from an earlier measurement. Everything else compares two ecosystems that were never the same to begin with.
What comparing your result with a reference group can tell you
Many reports show your own value alongside a reference group. This is useful as long as it is clear what is happening: your number is being compared with the numbers of other people tested using the same method at the same lab.
This leads to a practical rule. If you switch labs or methods, the reference range changes too. Putting two numbers from two different labs side by side and interpreting the difference is therefore not a comparison, but a calculation using two different yardsticks.
The objection is obvious: why have a reference group at all, then? Because it puts the magnitude into context. It tells you whether your value falls within the usual range for that group. It does not tell you whether it is good for you.
What moves the score up or down
The second common question after receiving a result is what can actually change the number. Four factors come up again and again, and they differ greatly in how much and how quickly they can shift it.
The first factor is diet. The Institute for Quality and Efficiency in Health Care describes the intestinal flora as billions of bacteria that feed, among other things, on the indigestible components of food (IQWiG, 2026). Indigestible here means what your small intestine does not absorb reaches the large intestine. Fiber is therefore not an add-on, but something that some of these bacteria feed on.
How much of it is recommended can be quantified. The German Nutrition Society recommends at least 30 grams of fiber per day for adults (DGE, 2021). This recommendation applies equally to adults in every age group from 19 onward.
The score describes the day you took the sample.
The second factor is antibiotics. The BfR explicitly lists antibiotic treatment among the factors that influence bacterial colonization (BfR, 2026). So if you had treatment shortly before taking the sample, you are measuring an exceptional situation, not your normal state.
The third factor is timing itself. The score describes the day you took the sample. A trip, an unusual week, an infection, or a holiday period with different foods all affect the number, without necessarily indicating a lasting change.
Why probiotics change the number less often than expected
The fourth factor is the one people expect the most from. After a low diversity score, reaching for a bacterial supplement seems like the obvious choice: low diversity, so add more bacteria.
In its statement from February 2026, the BfR describes a different finding. According to the statement, bacteria described as “probiotic” produce only temporary, non-significant changes in the overall structure and diversity of the stool microbiota (BfR, 2026). The assessment concerns infant formula, but it describes the effect on diversity itself.
This does not mean such products should be ruled out. It means that a diversity score is not the right way to measure their effectiveness. Using the number as a benchmark for a supplement means measuring the wrong thing.
What the value cannot tell you
A microbiome report does not provide a diagnosis. It describes a sample, not a disease. This boundary may sound like fine print, but it is actually the most important guide to reading the entire document.
This is clearest with irritable bowel syndrome, because it is often mentioned alongside the gut flora. IQWiG takes a cautious view of the evidence: It is suspected, among other things, that oversensitive intestinal nerves, disruptions in the intestinal muscles, changes in the gut flora, and inflammation of the intestinal wall may play a role (IQWiG, 2023). “Suspected” and “may” are the key words here.
The same source shows how common these symptoms are: Estimates suggest that about 10 to 20 out of every 100 people have irritable bowel syndrome, women about twice as often as men, and it first occurs most often between the ages of 20 and 30 (IQWiG, 2023). A diversity score cannot tell you anything about this. It can neither confirm nor rule out that someone is affected.
Three conclusions the score does not support
The first is the disease conclusion. A low score does not mean you have a disease, and a high score does not mean you are healthy. The score describes a structure, and structures are not findings about the person who has them.
The second is the cause-and-effect conclusion. If you have symptoms and also see a low score, it is almost automatic to connect the two. But their timing does not prove a link. An infection may also have caused both.
The third is the treatment conclusion. A number does not lead to a diet plan or treatment. A finding gives you a starting point for your own decisions and for a conversation, nothing more.
And one boundary must be stated clearly: persistent or new symptoms should be evaluated by a doctor, regardless of what the report says. IQWiG cites significant weight loss, blood in the stool, fever, or paleness as signs that may point to a different bowel disease (IQWiG, 2023). In such cases, a self-test is no substitute for an appointment; at most, it can help you prepare for one.
Chapter at a glance
A diversity score describes a sample, not a disease. It does not establish a diagnosis, a cause, or a treatment. IQWiG lists changes in the gut flora as one of several suspected factors in irritable bowel syndrome, not as a confirmed cause (IQWiG, 2023). Persistent or new symptoms should be discussed with a doctor, regardless of the findings.
Which test reports a diversity score
For a report to include a diversity metric at all, the method must be able to distinguish between species. A test that identifies only a few selected indicator microbes cannot show how many groups are represented. DNA sequencing-based methods can.
At mybody®x, the Gut Microbiome Test covers | Complete this section. The product page describes the analysis as DNA sequencing from a stool sample and explicitly lists biodiversity as one of the reported values (information from the product page, accessed on 27.08.2026).

Gut test using a stool sample
Gut Microbiome Test | Complete
DNA sequencing of the gut microbiota, reporting biodiversity and other metrics such as the Firmicutes-Bacteroidetes ratio and butyrate production potential. What the test does not do: diagnose conditions, identify the cause of symptoms, or provide a target number you need to reach.
Lab analysis: 5–10 business days after sample receipt
Information from the product page, accessed 27.08.2026
One detail is deliberately omitted here, and there’s a reason: our own pages describe the number of species the method distinguishes on different scales. Until that’s clarified, this article won’t give a number. An unverified figure would be the worse mistake.
The Gut Bacteria Guide explains what each bacterium and metric in the report means, entry by entry. It’s the place to look when you come across a name in your results that you’ve never seen before.
Is a second measurement worthwhile?
Chapter 3 leads to a practical conclusion: If your own earlier result is the best benchmark, then a single report only becomes truly meaningful when you have a second one. The only question is when it's worthwhile and when it isn't.
It may be useful for you if …
you've made a noticeable change to your diet and want to know whether the same measurement has changed.
the first report was produced shortly after antibiotic treatment or an infection, and you need a snapshot without those exceptional circumstances.
you're planning a longer-term change and want a baseline to measure against later.
Probably not, if …
you're hoping for a diagnosis or the cause of your symptoms. The metric can't provide either.
only a few weeks have passed since the first sample and nothing has changed in your daily life.
you have significant symptoms. Those should be addressed first at a doctor's office, not with a second self-test.
The two measurements need to be comparable. The same lab, the same method, and ideally similar sampling conditions. Two measurements from two different labs give you two snapshots, but no indication of a trend.
If you recognize yourself on the right, that's not a rejection of the topic, just a matter of timing. Monitoring costs nothing, and a report doesn't expire.
What you can do with the number
At first, it seemed that the diversity score was the result and the species list below it was just extra detail. It's actually the other way around: The list is the measurement; the number summarizes it. Read it this way, and you'll expect less of the number and get more out of it.
Two sentences are enough to remember. Differences between two people are large from the outset (BfR, 2026) - that undermines the basis for comparing your results with other people's. And the result describes the day the sample was taken, not your usual state.
The takeaway is simple. Write down the result, lab and date somewhere you can find them again in a year. Without these three details, a second measurement later is just another standalone number.
And something practical for next week: Look at where fiber shows up in your day. Don't count, just take a look. The guideline of at least 30 grams per day (DGE, 2021) is hard to meet if two out of three meals contain none.
If you're unsure whether your report even addresses your question: The consultation is free, and it won't try to sell you anything.
Frequently asked questions
What does a low diversity score in a microbiome report mean?
It means that in this one sample, either few bacterial groups were found or the amount found was distributed very unevenly among them. You cannot infer a disease from this. BfR (2026) notes that differences between individuals are already considerable to begin with.
Can I compare my value with someone else’s?
Only to a limited extent. Two people have different starting points, and two laboratories calculate results against different reference groups. The value becomes meaningful when you compare it with your own earlier value from the same method.
Does the diversity score show whether my gut is healthy?
No. The value describes the structure of a sample, not a person’s state of health. There is no established target value for individuals for any of the three common metrics in the report. Anyone seeking to rule out or confirm a disease needs a medical evaluation.
How quickly does the value change?
Short-term influences such as travel, an infection, or antibiotic treatment show up immediately in a sample. Only a later measurement under the same conditions can show whether a change persists. Regarding added bacteria, BfR (2026) describes only temporary, non-significant changes in overall diversity.
When should a microbiome test result be discussed with a doctor?
As soon as symptoms arise that do not go away. IQWiG (2023) lists significant weight loss, blood in the stool, fever, or paleness as signs that may point to a different intestinal disease. In these cases, making an appointment is the first step, and the test result is at most supporting material for the discussion.
Next step
If you want to track a diversity score that you can measure again later
The Microbiome Gut Test | Complete uses DNA sequencing from a stool sample and reports biodiversity as a separate value. The gut glossary explains what each metric and bacterial name in the report means.
Go to the Microbiome Gut Test Go to the gut glossaryRead more
You might also be interested in
How to tell which testing method is right for your question.
What can actually change, and over what period.
Every name and metric in your report, explained individually.
Sources
- Federal Institute for Risk Assessment (BfR): Health benefits of infant formula with added “probiotics” still not scientifically proven, statement 005/2026 (February 3, 2026) – bfr.bund.de
- Institute for Quality and Efficiency in Health Care (IQWiG): How does the gut work? (as of June 24, 2026) – gesundheitsinformation.de
- Institute for Quality and Efficiency in Health Care (IQWiG): Irritable Bowel Syndrome (as of 02/22/2023) – gesundheitsinformation.de
- German Nutrition Society (DGE): Reference Values for Fiber (2021 derivation) – dge.de
The verbatim quote about interindividual differences, the list of factors influencing early bacterial colonization, and the assessment of bacterial supplements come from [1]; the statement addresses infant formula, and this connection is disclosed in the text. The description of the gut flora and its nutrition comes from [2] and is presented with attribution because the original sentence begins with a referential word. The information on the prevalence of irritable bowel syndrome, gender distribution, age at first onset, suspected factors, and warning signs comes from [3]. The guideline value of at least 30 grams of fiber per day comes from [4]. All four sources were accessed and checked live on 08/27/2026. Information on price, method, metrics, sample type, and laboratory comes from the mybody®x product page and gut encyclopedia, accessed on 08/27/2026; processing times follow the central specification for each test type. No number of species is given because the company’s own pages cite different figures.
mybody®x Editorial & Subject-Matter Team
Microbiome and gut science Nutritional science Laboratory diagnostics
This article was created by the mybody®x editorial and subject-matter team. The team brings together microbiome and gut science, nutritional science, and laboratory diagnostics. Learn who contributed on the authors page.
Published on 08/27/2026 · Last updated on 08/27/2026
The content is for general information and does not replace medical advice, diagnosis, or treatment. Reference ranges vary by laboratory, method, and age—the information on your results is always authoritative.

